First American Trust’s bluebird bio BLUE Stock Holding History

First American Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-977	Closed	-$1.11M	–	112
2019 Q4	$1.11M	Buy	977 +6	+0.6%	+$6.52K	0.21%	77
2019 Q3	$1.16M	Sell	971 -8	-0.8%	-$12.2K	0.23%	73
2019 Q2	$1.61M	Buy	979 +25	+3%	+$43.3K	0.34%	72
2019 Q1	$1.95M	Buy	+954	New	+$1.68M	0.43%	69

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First American Trust's BLUE Position: Q1 2020 in Review

First American Trust sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 977 shares — an estimated $1.11M sold.

First American Trust first reported a position in BLUE in Q1 2019 and held it in 4 quarters. The position peaked at $1.95M in Q1 2019. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

First American Trust reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
First American Trust sold 977 bluebird bio shares in Q1 2020, an estimated $1.11M.
First American Trust first reported a position in bluebird bio in Q1 2019 and held it in 4 quarters.
First American Trust's bluebird bio position peaked at $1.95M in Q1 2019.
247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on First American Trust's 13F filing for Q1 2020, filed 28 Apr 2020.